Product Information
GLATIRAMER 20 MG/ML SYRINGE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $45.7269 per ML under NDC 00378696093. Its NADAC has been published 167 times since Aug 19, 2020.
Strength
20 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378696093
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
GLATIRAMER ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA091646On Market Since
10/4/2017
Price Statistics
The NADAC for GLATIRAMER 20 MG/ML SYRINGE has been published 167 times since Aug 19, 2020, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $45.7269 per ML |
|---|---|
| All-time high | $52.0697 (Aug 11, 2021) |
| All-time low | $43.7485 (Mar 18, 2026) |
| 52-week high | $48.4997 |
| 52-week low | $43.7485 |
| Median price | $48.4997 |
| Average price | $48.8073 |
| Largest weekly change | +6.9% (Oct 23, 2024) |
| Weeks tracked | 167 |
| Tracking since | Aug 19, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the glatiramer acetate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GLATIRAMER 20 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for GLATIRAMER 20 MG/ML SYRINGE, manufactured by Mylan Pharmaceuticals Inc., is $45.7269 per ML (NDC 00378696093), effective Jun 24, 2026.
How has the price of GLATIRAMER 20 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for GLATIRAMER 20 MG/ML SYRINGE has declined 12.2%. It has been tracked across 167 weekly CMS publications since Aug 19, 2020.
What are the highest and lowest recorded NADAC prices for GLATIRAMER 20 MG/ML SYRINGE?
Since Aug 19, 2020, the NADAC for GLATIRAMER 20 MG/ML SYRINGE has ranged from a low of $43.7485 (Mar 18, 2026) to a high of $52.0697 (Aug 11, 2021), with a median of $48.4997 per ML.
Are there cheaper alternatives to GLATIRAMER 20 MG/ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GLATIRAMER 20 MG/ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures GLATIRAMER 20 MG/ML SYRINGE?
GLATIRAMER 20 MG/ML SYRINGE (NDC 00378696093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification